![Sundar Kodiyalam](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sundar Kodiyalam
Directeur/Membre du Conseil chez
ALSP ORCHID ACQUISITION CORPORATION I
Profil
Sundar Kodiyalam is the founder of Vatera Healthcare Partners.
Current jobs include Director at Global Alliance for TB Drug Development since 2021, Director at Edgemont Pharmaceuticals LLC since 2011, Director at Talaria Therapeutics, Inc., Managing Director at Oikos Holdings LLC, Director at Ekteino Laboratories, Inc., Director at Lodo Therapeutics Corp., Director at ALSP Orchid Acquisition Corp.
I, Director at Amplipharm LLC, Director at EG 427 SAS since 2023, Vice President at Forticell Bioscience, Inc., and Senior Advisor at Accelerator Services Corp.
Former jobs include Director-Business Development & Licensing at Schering-Plough Corp., Director at ASCIO Pharmaceuticals, Inc., Director at Melinta Subsidiary Corp., Director-Business Development & Licensing at Novartis Pharmaceuticals Corp., Director at Pearl Therapeutics, Inc., Director at ImmusanT, Inc., Vice President-Commercial Development at Forticell Bioscience, Inc., and Senior Vice President-Corporate Development at KOS Pharmaceuticals, Inc. Education includes a graduate degree from The Ohio State University and an undergraduate degree from the University of Madras.
Postes actifs de Sundar Kodiyalam
| Sociétés | Poste | Début |
|---|---|---|
| ALSP ORCHID ACQUISITION CORPORATION I | Directeur/Membre du Conseil | - |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Genelpis SAS
 Genelpis SAS BiotechnologyHealth Technology Operates as a biotechnology company that develops pinpoint DNA medicines for chronic diseases | Directeur/Membre du Conseil | 27/03/2023 |
Amplipharm LLC | Directeur/Membre du Conseil | - |
Talaria Therapeutics, Inc.
 Talaria Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops technology for treating cardiovascular disease | Directeur/Membre du Conseil | - |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Develops tuberculosis drugs | Directeur/Membre du Conseil | 30/09/2021 |
Lodo Therapeutics Corp.
 Lodo Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel therapeutics | Directeur/Membre du Conseil | - |
Ekteino Laboratories, Inc.
 Ekteino Laboratories, Inc. BiotechnologyHealth Technology Develops sustained-release drug delivery system for chronic use medications | Directeur/Membre du Conseil | - |
Edgemont Pharmaceuticals LLC
 Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Directeur/Membre du Conseil | 01/01/2011 |
| ░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Anciens postes connus de Sundar Kodiyalam
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Sundar Kodiyalam
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Forticell Bioscience, Inc.
 Forticell Bioscience, Inc. BiotechnologyHealth Technology Advances regenerative medicine through development of cellular technology & advanced biomaterial products | Health Technology |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Develops tuberculosis drugs | Health Technology |
ASCIO Pharmaceuticals, Inc.
 ASCIO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Edgemont Pharmaceuticals LLC
Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Health Technology |
Talaria Therapeutics, Inc.
Talaria Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops technology for treating cardiovascular disease | Commercial Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Madras
 University of Madras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Finance |
Oikos Holdings LLC
 Oikos Holdings LLC Investment ManagersFinance Operates as a holding company that provides financial advisory services | Finance |
Pearl Therapeutics, Inc.
 Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of chronic respiratory diseases | Health Technology |
Vatera Healthcare Partners
 Vatera Healthcare Partners Investment ManagersFinance Vatera Healthcare invests in companies located in the United States. The firm targets companies operating across wide variety of biopharmaceutical sector. It provides financing for seed, early and later stage capital requirements. | Finance |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company which develops a treatment, and a set of diagnostic and monitoring tools to manage patients with celiac disease | Health Technology |
Ekteino Laboratories, Inc.
Ekteino Laboratories, Inc. BiotechnologyHealth Technology Develops sustained-release drug delivery system for chronic use medications | Health Technology |
Lodo Therapeutics Corp.
Lodo Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel therapeutics | Health Technology |
Genelpis SAS
Genelpis SAS BiotechnologyHealth Technology Operates as a biotechnology company that develops pinpoint DNA medicines for chronic diseases | Health Technology |
ALSP Orchid Acquisition Corp. I
 ALSP Orchid Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
Amplipharm LLC |
